BioCentury
ARTICLE | Financial News

Aileron raises $40 million

June 9, 2009 1:53 AM UTC

Aileron Therapeutics Inc. (Cambridge, Mass.) raised $40 million in a series D round co-led by new investors SR One and Excel Medical Ventures. Lilly Ventures and Roche Venture Fund, also new investors, and existing investors Apple Tree Partners and Novartis Venture Funds participated. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article